| Authors: |
Kalkowska DA; Kid Risk, Inc., Orlando, FL, USA., Pallansch MA; National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Wilkinson A; Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA., Bandyopadhyay AS; Bill and Melinda Gates Foundation, Seattle, WA, USA., Konopka-Anstadt JL; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Burns CC; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Oberste MS; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Wassilak SGF; Global Immunization Division, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, GA, USA., Badizadegan K; Kid Risk, Inc., Orlando, FL, USA., Thompson KM; Kid Risk, Inc., Orlando, FL, USA. |
